Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03183102 · ClinicalTrials.gov registry record · NA

The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator.

A NA study of Menopause, sponsored by Colorado State University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT03183102 is a NA study of Menopause that has completed, run by Colorado State University. The registered enrollment target is 30 participants, below the 9,394-participant average among 54 other Menopause trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03183102, a NA study of Menopause, has completed, sponsored by Colorado State University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot study is to determine if suppressing estrogen in premenopausal women results in changes in gut microbiota and if dietary flaxseed modulates these changes.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Flaxseed

Study Locations (1)

Colorado

  • Colorado State University - Fort Collins

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-10-01
Est. Completion 2022-12-30
Phase NA

Sponsor

Colorado State University

94 total trials

What the Registry Record Tells You About NCT03183102

The ClinicalTrials.gov registry entry for NCT03183102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,394-participant average among 54 other Menopause trials with a reported enrollment target (100% lower). The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Menopause appearing as the primary indexed condition, and to 1 intervention - of which Flaxseed is the first listed.

NCT03183102 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT03183102 about?

NCT03183102 is a clinical study titled "The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator.". The purpose of this pilot study is to determine if suppressing estrogen in premenopausal women results in changes in gut microbiota and if dietary flaxseed modulates these changes.

What is the current status of trial NCT03183102?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-10-01. Estimated completion is 2022-12-30.

What conditions does trial NCT03183102 study?

This clinical trial studies the following conditions: Menopause.

What interventions are being tested in trial NCT03183102?

The interventions under investigation include: Flaxseed (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03183102?

This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03183102 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Menopause

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.